Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 17.52M | $1.15B | -- | +8.13M | 2026-03-31 |
| BlackRock, Inc. | 16.55M | $1.09B | -- | +152.9K | 2026-03-31 |
| FMR LLC | 10.72M | $706.0M | -- | -2.08M | 2026-03-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.01M | $527.0M | -- | +72.4K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.84M | $385.0M | -- | -- | 2026-03-31 |
| STATE STREET CORP | 5.75M | $378.0M | -- | -80.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.49M | $361.0M | -- | -- | 2026-03-31 |
| Avoro Capital Advisors LLC | 3.33M | $219.0M | -- | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.22M | $211.0M | -- | +159.4K | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 3.13M | $205.0M | -- | +184.3K | 2026-03-31 |
